FDA recall D-0507-2022
Ultra Seal Corporation · Class II · drug
Product
Exaprin pain reliever (acetaminophen 110 mg, aspirin 162 mg, caffeine 32.4mg, salicylamide 152mg) tablets, 2- tablet packets, Manufactured for: HARTHealth Seattle, WA 98124
Reason for recall
cGMP deviations
Distribution
Nationwide within the United States
Key facts
- Status
- Terminated
- Initiation date
- 2022-01-24
- Report date
- 2022-02-09
- Termination date
- 2023-10-16
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- New Paltz, NY, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0507-2022